Waltham-based Avedro said Muller left to “pursue other opportunities.”
“On behalf of the board and all the Avedro employees, I want to thank David for his tireless efforts. Ophthalmologists around the world have David to thank for the advances in corneal cross-linking that Avedro researched, developed and commercialized around the world under his leadership,” director Dr. Gil Kliman said in prepared remarks.
Avedro, which also announced CE Mark approval in the European Union for its Mosaic low myopia treatment, said it hopes to have its KXL treatment on the U.S. market in the 2nd half of 2016.
Derma Sciences CEO Quilty steps down
Derma Sciences (NSDQ:DSCI)
said it agreed with chairman & CEO Edward Quilty that it’s time for him to step down, effective Dec. 21, but remain on the board and serve as a consultant. Quilty was replaced with lead director Stephen Wills while the company conducts a search for a replacement.
Getinge names Fabricius to replace Grunander at CFO
Getinge (PINK:GETI B) said it named Pernille Fabricius to replace Ulf Grunander at the CFO spot, upon Grunander’s retirement after 23 years as finance chief.